In this paper we are reporting inadequacy of human, material and financial resources for histological data collection through a case of 21-year-old patient with lymphoma complicated by acute renal failure.
Introduction
Nephrology is a relatively new discipline in Africa, particularly in black African countries. The diagnosis of some renal diseases, such as the renal complications of non-Hodgkin's malignant lymphoma (NHML), is histological. The authors are reporting difficulties in obtaining histological data in a case of lymphoma secondary to acute renal failure (ARF).
Case Presentation
This is a 21-year-old male patient hospitalized for the treatment of ARF. His history goes back to approximately 4 weeks, prior to his admission for a bilateral lower back pain not suggestive of renal colic and was associated with asthenia. Patient referred to a clinic, where the physical examination results were virtually normal indicating stable hemodynamic condition without fever. The CBC revealed anemia of 10.5 g/dL, while, other parameters of the CBC were normal. Serum creatinine was 20mg/l (177 μmol/L). The thick blood smear was negative. However, the patient received anti-malarial treatment with injectable artemether (a drug to treat malaria) for three days on an outpatient basis without success. The clinical presentation worsened with the appearance of a discrete bilateral parotid swelling and lower limb edema. During a 2 nd consultation, he benefited from a symptomatic treatment with oral furosemide. His subsequent progress was marked by the occurrence of an altered general health. He attended another health facility where the laboratory tests revealed a C-reactive protein (CRP) of 22 mg/L and a serum creatinine of 80 mg/L (708 μmol/L). The patient was then referred to the nephrology department for the management of his renal failure.
The interview did not reveal any particular past medical history or nephrotoxic drug intake. The physical examination identified bilateral edema of the lower extremities, fine crackling in the left lung field, and painless febrile cervical, submandibular and inguinal poly-lymphadenopathy. There was also a bilateral lower back pain without lumbar contact. There was neither hepatomegaly nor splenomegaly.
Biologically, renal function was impaired with urea of 1.98 g/L (33.66 mmol/L)) and serum creatinine of 88 mg/L (779 μmol/L). The blood electrolytes and transaminases were normal. There was anemia of inflammation with hemoglobin of 9.5 g/dL. The other parameters of the CBC were normal. The CRP was 24 mg/L. The LDH were elevated to 1284 IU/L. Serology for HIV, hepatitis B and C, and syphilis tests were negative. The urine strip test showed presence of protein without leucocytes, red blood cells or nitrites. The 24-hour proteinuria was 0.24 g.
The chest X-ray showed left perihilar alveolar opacities. There was no mediastinal adenopathy.
On ultrasound, the kidneys had a normal size with multiple hypoechoic nodules formations with no dilatation of the pyelocalyceal cavities. The liver had a normal size, and was heterogeneous with multiple disseminated hypoechoic nodules formations. There was neither ascites nor deep lymphadenopathy.
NHML was strongly suspected during the fine-needle non-aspiration cytology of the cervical lymph nodes. The inguinal lymph node biopsy detected a small-cell NHML (Figure 1) .
The kidney and liver biopsies could not perform due to lack of biopsy needles during the patient's hospitalization period.
The diagnosis of diffuse small-cell NHML (with kidney and liver involvement) associated with pneumonitis was made. There was a favorable outcome of pneumonia with antibiotic therapy. Given the renal failure severity, he underwent a total of six hemodialysis sessions.
Immunohistochemistry could not perform while the patient died before starting the chemotherapy, after one week of hospitalization.
Discussion
The clinical manifestations of renal lymphomas are predominated by the classic triad of: lumbar mass, lower back pain and hematuria. This triad was associated with an altered general health or fever. Our patient presented only with altered general health and lower back pain. There was no hematuria. Renal involvement is either secondary to hematogenous diffusion in the context of multi-organ involvement or due to contiguous retroperitoneal lymphadenopathy. In rare cases, renal involvement may be primitive as reported by some authors (1, 2) . The diagnostic criteria for primary renal lymphoma consist of (3); • Initial presentation in the form of unexplained ARF • Increase in the kidneys size • The diagnosis is confirmed by the histological assessment of the kidneys • Absence of extra-renal lymphomatous involvement • Regression of symptomatology after treatment In our patient case, we suspected kidney involvement secondary to hematogenous diffusion in this context of multi-organ involvement (kidney involvement with multiple hypoechoic nodules formations, ARF and liver involvement with multiple hypoechoic nodules formations). Kidney involvement by contiguity was ruled out in our case in the absence of retro-peritoneal adenopathy. Moreover, this case did not meet the diagnostic criteria for primary renal lymphoma, since the kidneys did not increase in size and he presented with extra-renal lymphomatous involvement (cervical and inguinal lymphadenopathies).
The involvement may also be secondary to an immunological mechanism. The diagnosis of renal lymphoma is histological. In our patient case, the kidney biopsy could not perform owing to stock-out of biopsy needles. However, in view of the fine-needle nonaspiration cytology of the cervical lymph nodes strongly suspected of non-Hodgkin's malignant lymphoma. The histological diagnosis of lymphoma made for the inguinal lymph node biopsy. The final diagnosis of NHML with probably extra-ganglionic localizations was conducted based on the ultrasound images of the liver and kidneys, which was complicated by ARF.
Indeed, the pharmacy of the University Teaching Hospital of Yopougon (a city of Abidjan) does not have renal biopsy needle, or single-use renal biopsy gun yet. We have been performing percutaneous renal biopsy since 2010 using a biopsy gun to which we fix the needles. This gun is graciously made available to the nephrology department by a physician of that department. The city pharmacies also have neither needles nor kidney biopsy guns. This is probably due to the low demand, while there are only two public departments of nephrology in Côte d'Ivoire. The supply of needles has been made by a private supplier engaging in informal-sector activities with often stock-out periods.
The minimum cost of performing a renal needle biopsy is 167 000 CFA francs (i.e. € 254.6 or US$310). It includes the purchase of the biopsy needle, asepsis equipment, local anesthesia, analgesics, the costs of 2-day hospitalization in the absence of complications and the costs of the anatomical pathology examination. This cost amounts to € 243.22 (US$299) in France (4) and US$1968 (€ 1600) in the United States (5) , where health insurance has been provided by private insurance companies. This cost of € 254.6 is high for our population, while, the majority of whom are poor without health insurance coverage.
Besides the lack of material and financial resources, there is a shortage of pathologists (see Table 1 ). In Côte d'Ivoire, there is only one pathologist who specialized in renal pathology for a population of 24.4 million inhabitants (6). The majority of French-speaking African countries do not have pathologists who specialized in renal pathology. In 2017, France had 1618 pathologists of all specialties (7).
In terms of treatment, there are several modalities; chemotherapy, surgery or radiotherapy (8) . With regard to chemotherapy, it is actually multi-agent chemotherapy, mostly the CHOP type (cyclophosphamide, doxorubicin, vincristine, and prednisone), which is increasingly associated with rituximab. It gives better results as compared to conventional chemotherapy (9) .
Conclusion
Histology is essential for diagnosis, therapy and prognosis of several kidney diseases. However, when performing renal needle biopsy, we encounter several barriers in our developing countries, particularly in Africa. These barriers can be summed up in the lack of human, material and financial resources. 
